UBS Maintains Neutral on Paychex, Lowers Price Target to $115
UBS analyst Kevin Mcveigh maintains Paychex (NASDAQ:PAYX) with a Neutral and lowers the price target from $125 to $115.
Stocks · News reference
Reported earlier, Paychex Sees Q2 Sales $1.620B vs $1.638B Est
Paychex (NASDAQ:PAYX) sees Q2 sales of $1.620 billion vs $1.638 billion analyst estimate.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
BMO Capital Maintains Market Perform on Paychex, Lowers Price Target to $113
BMO Capital analyst Daniel Jester maintains Paychex (NASDAQ:PAYX) with a Market Perform and lowers the price target from $118 to $113.
These Analysts Revise Their Forecasts On Paychex Following Q1 Results
Paychex beats Q1 FY27 estimates, maintains guidance; analysts adjust targets as shares slip 1.4%.
Stifel Maintains Hold on Paychex, Lowers Price Target to $112
Stifel analyst David Grossman maintains Paychex (NASDAQ:PAYX) with a Hold and lowers the price target from $130 to $112.